StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
TR8.AX$0.01+0.00%
Fair $0.01+0.0%

TR8.AX

TR8.AX

Consumer Defensive / Packaged FoodsASX

$0.01

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $0.01Fund rank 30/100 · Data gapFallback financials|
SA 28/D
F-Score: 0/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 23%

FCF escenarios

weak_data · normalized FCF $-94435.00 · quality 66.7/100

Data gap 30/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 31/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

28/100

D

Piotroski

0/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · TR8.AXLocal privado en este navegador · TR8.AX
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$6M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

23.4%

↑

Gross Margin

N/A

•

Debt/Equity

-0.79

↓
52-Week Range$0
$0$0

TradingView lightweight chart

TR8.AX price, volumen y niveles de valoración

Último $0.015Periodo -94.0%
Fair value: $0.015

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

—

FCF CAGR

—

FCF margin

—

FCF / Net income

0.39x

Latest source

Provider fallback

Margin decomposition

Último año: revenue — · net income $-240933.0 · FCF $-94435.0

2022-FY → 2025-FY

Gross margin

—— pts

Operating margin

—— pts

Net margin

—— pts

FCF margin

—— pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue———$5.5M$5.3M
Net Income$-240933.00$-240933.00$1.4M$-3.3M$-3.5M
EBITDA$-154642.00$-154642.00$-670367.00$-3.0M$-3.2M
EPS-0.01-0.010.01-0.05-0.05
Gross Margin———38.2%47.9%
Operating Margin———-62.1%-66.0%
Net Margin———-60.2%-65.9%
Balance Sheet
Debt/Equity-0.79-0.79-0.80-0.610.28
Current Ratio18.3318.33———
Cash Flow
Free Cash Flow$-94435.00$-94435.00$13521.00$-3.6M$-2.6M
Returns
ROE23.4%23.4%-177.2%241.8%-212.2%
Valuation
P/E——0.47——
P/B————3.97
Growth & Yield
Revenue Growth———3.5%—
EPS Growth-198.8%-198.8%117.8%6.6%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +275.0%

Total return

+275.0%

Start / end P/E

n/dx → n/dx

EPS bridge

0.01 → -0.01

Residual

+275.0%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+275.0%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.